Protamine zinc insulin combined with sodium selenite improves glycometabolism in the diabetic KKAy mice.
Ontology highlight
ABSTRACT: Long-term, high dosage protamine zinc insulin (PZI) treatments produce adverse reactions. The trace element selenium (Se) is a candidate for the prevention of diabetes due to anti-oxidative stress activity and the regulation of glycometabolism. In this study, we aimed to investigate the anti-diabetic effects of a combination of PZI and Se on type 2 diabetes. Diabetic KKAy mice were randomized into the following groups: model group and groups that were subcutaneously injected with PZI, Se, high or low dose PZI + Se for 6 weeks. PZI combined with Se decreased the body weight and fasting blood glucose levels. Moreover, this treatment also improved insulin tolerance, as determined by the reduced values from the oral glucose tolerance test and insulin tolerance test, and increased insulin level
SUBMITTER: Lu J
PROVIDER: S-EPMC4876423 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
ACCESS DATA